Cost-Effectiveness of Digital Mammography Screening Questioned

For the Medicare-aged (older) population, digital mammography provided no apparent benefit and there was a suggestion that film mammography may be better for older women with non-dense breasts.

"It was important for us to learn how changes in breast cancer detection project into changes in life expectancy. Only by considering long-term health outcomes can we assess the value of the digital mammography relative to other healthcare interventions,” said lead author Dr. Anna N.A. Tosteson, a Dartmouth Medical School professor of medicine and of community and family medicine. "What we found is that the higher cost of digital mammography is not justified by better health outcomes unless its use is directed to younger women or those with dense breast tissue,” continued Dr. Tosteson, also from the Dartmouth Institute for Health Policy and Clinical Practice and the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center.

Data for the study were collected through the Digital Mammography Imaging Screening Trial (DMIST), which involved more than 42,000 women in the United States and Canada. The cost-effectiveness analysis determined work-up costs associated with digital versus film and projected long-term health outcomes using computer simulation methods. Based on Medicare prices, the cost of a digital mammogram is about US$50 higher than the cost of a traditional film mammogram.

Although rates have been declining, breast cancer remains the second-leading cause of cancer death among women in the United States. The U.S. National Cancer Institute and others, attribute a decrease in breast cancer deaths in part to an increase in detection through regular mammograms. Currently, about 33.5 million mammograms are conducted in the United States each year.

This research was published in the January 1, 2008, issue of the journal Annals of Internal Medicine.


Related Links:
Dartmouth Medical School